STING1 and Hyperglycemia: Following intraperitoneal injection of STZ, STING‐deficient mice also exhibited marked hyperglycaemia (Figure 1a), accompanied by hypoinsulinaemia (Figure 1b), with no significant difference compared with WT diabetic mice.